Member satisfaction related to self-reported cost share and difficulty in obtaining prescription drugs in a university pharmacy benefit plan

Journal of Managed Care Pharmacy

Volumn 13, Issue 2, 2007, Pages 135-141

  Nau, David P ^a   Chi, Christina ^b   Mallya, Usha ^c   Kirking, Duane M ^b  

^a University of Kentucky   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Novartis   (United States)

Author keywords

Access; Drug benefit; Member satisfaction

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DONEPEZIL; METHYLPHENIDATE; NONSTEROID ANTIINFLAMMATORY AGENT; SILDENAFIL;

ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT CARE PLANNING; PATIENT SATISFACTION; PHARMACEUTICAL CARE; PRESCRIPTION;

EID: 33947617760     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2007.13.2.135     Document Type: Article

References (14)

1. Mercer Health & Benefits. Hot topics in health care: pharmacy benefits. Summary of results. Available at: http://wrg.mercerhr.com/ content_print.asp?article_id=20066135&ext=.PDF. Accessed May 4, 2006.
2. Cox ER, Henderson R, Motheral BR. Health plan member experience with point-of-service prescription step therapy. J Manag Care Pharm. 2004;10(4): 291-98. Available at: http://www.amcp.org/data/jmcp/ Research-291-298.pdf. Accessed January 22, 2007.
3. Motheral BR, Henderson R, Cox ER. Plan-sponsor savings and member experience with point-of-service prescription step therapy. Am J Manag Care. 2004;10:457-64.
4. Nair KV, Ganther JM, Valuck RJ, McCollum MM, Lewis SJ. Impact of multitiered pharmacy benefits on attitudes of plan members with chronic disease states. J Manag Care Pharm. 2002;8:477-91. Available at: http://www.amcp.org/data/jmcp/Research-477-491.pdf. Accessed January 22, 2007.
5. Desselle S. Development of an interval-level scale to assess consumer satisfaction with prescription drug coverage. J Manag Care Pharm. 2000;6(3):225-31.
6. Desselle S. Determinants of satisfaction with prescription drug plans. Am J Health Syst Pharm. 2001;58:1110-19.
7. Motheral BR, Heinle SM. Predictors of satisfaction of health plan members with prescription drug benefits. Am J Health Syst Pharm. 2004;61:1007-14.
8. Kaiser Family Foundation (KFF) and the Health Research and Educational Trust (HRET). 2005 employer health benefits annual survey Available at: http://www.kff.org/insurance/7315/sections/upload/7316.pdf. Accessed May 4, 2006.
9. Holdford D, Carroll NV. Consumer preferences for types of cost containment in prescription drug programs. J Manag Care Pharm. 2002;8:192-98. Available at: http://www.amcp.org/data/jmcp/ Research-192-198.pdf. Accessed January 22, 2007.
10. VanHamme J. The link between surprise and satisfaction: an exploratory research on how best to measure surprise. J Market Manag. 2000;16:565-82.
11. VanHamme J, Snelders D. The role of surprise in satisfaction judgment. J Consumer Satisfaction, Dissatisfaction Complaining Behav. 2001;14:27-45.
12. David K, Schoen C. Assuring quality, information, and choice in managed care. Inquiry. 1998;35:104-14.
13. Tucker JL. Patients' knowledge of health plan coverage and satisfaction with care. Am J Manag Care. 2001;7:453-59.
14. Olson BM, Malone DC, Zachary WM, Coons SJ. Consumer understanding and satisfaction associated with a 3-tier prescription drug benefit. J Manag Care Pharm. 2005;11(6):480-92. Available at: http://www.amcp.org/data/ jmcp/4.pdf. Accessed January 22, 2007.